Einar Klæboe Kristoffersen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Einar Klæboe Kristoffersen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Kristine Mørch
Department of Clinical Science, Lab-building 8.floor, University of Bergen, N-5021, Bergen, Norway
2 shared publications - Kurt Hanevik
Department of Clinical Science, University of Bergen, Bergen, Norway
2 shared publications Roald Matre
Department of Microbiology and Immunology, The Gade Institute, University of Bergen, Bergen, Norway
2 shared publications- Ann C Rivenes
Division of Psychiatry, Haukeland University Hospital, Bergen, Norway
1 shared publication - Halvor Naess
Department of Neurology, Haukeland University Hospital, Bergen, Norway
1 shared publication - Jostein Førsvoll
Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway
1 shared publication
Latest Publications
- Open Access
- 28 January 2017
- Published by Springer Nature in BMC Immunology
- Vol. 18 (1) , 1-8
Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome
The role of pathogen specific cellular immune responses against the eliciting pathogen in development of post-infectious chronic fatigue syndrome (PI-CFS) is not known and such studies are difficult to perform. The aim of this study was to evaluate specific anti-Giardia cellular immunity in cases that developed CFS after Giardia infection compared to cases that recovered well. Patients reporting chronic fatigue in a questionnaire study three years after a Giardia outbreak were clinically evaluated five years after the outbreak and grouped according to Fukuda criteria for CFS and idiopathic chronic fatigue. Giardia specific immune responses were evaluated in 39 of these patients by proliferation assay, T cell activation and cytokine release analysis. 20 Giardia exposed non-fatigued individuals and 10 healthy unexposed individuals were recruited as controls. Patients were clinically classified into CFS (n = 15), idiopathic chronic fatigue (n = 5), fatigue from other causes (n = 9) and recovered from fatigue (n = 10). There were statistically significant antigen specific differences between these Giardia exposed groups and unexposed controls. However, we did not find differences between the Giardia exposed fatigue classification groups with regard to CD4 T cell activation, proliferation or cytokine levels in 6 days cultured PBMCs. Interestingly, sCD40L was increased in patients with PI-CFS and other persons with fatigue after Giardia infection compared to the non-fatigued group, and correlated well with fatigue levels at the time of sampling. Our data show antigen specific cellular immune responses in the groups previously exposed to Giardia and increased sCD40L in fatigued patients.
- 28 January 2017
- Published by Springer Nature in BMC Immunology
- Vol. 18 (1) , 1-8
Open AccessGiardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome
The role of pathogen specific cellular immune responses against the eliciting pathogen in development of post-infectious chronic fatigue syndrome (PI-CFS) is not known and such studies are difficult to perform. The aim of this study was to evaluate specific anti-Giardia cellular immunity in cases that developed CFS after Giardia infection compared to cases that recovered well. Patients reporting chronic fatigue in a questionnaire study three years after a Giardia outbreak were clinically evaluated five years after the outbreak and grouped according to Fukuda criteria for CFS and idiopathic chronic fatigue. Giardia specific immune responses were evaluated in 39 of these patients by proliferation assay, T cell activation and cytokine release analysis. 20 Giardia exposed non-fatigued individuals and 10 healthy unexposed individuals were recruited as controls. Patients were clinically classified into CFS (n = 15), idiopathic chronic fatigue (n = 5), fatigue from other causes (n = 9) and recovered from fatigue (n = 10). There were statistically significant antigen specific differences between these Giardia exposed groups and unexposed controls. However, we did not find differences between the Giardia exposed fatigue classification groups with regard to CD4 T cell activation, proliferation or cytokine levels in 6 days cultured PBMCs. Interestingly, sCD40L was increased in patients with PI-CFS and other persons with fatigue after Giardia infection compared to the non-fatigued group, and correlated well with fatigue levels at the time of sampling. Our data show antigen specific cellular immune responses in the groups previously exposed to Giardia and increased sCD40L in fatigued patients.
- Open Access
- 17 October 2013
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 11 (1) , 38
Elevated levels of CXCL10 in the Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) during and between febrile episodes; an indication of a persistent activation of the innate immune system
The Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) is the most common periodic fever syndrome in childhood. Clinically, PFAPA may resemble autoinflammatory diseases, but the etiology is not fully understood.
- 17 October 2013
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 11 (1) , 38
Open AccessElevated levels of CXCL10 in the Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) during and between febrile episodes; an indication of a persistent activation of the innate immune system
The Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) is the most common periodic fever syndrome in childhood. Clinically, PFAPA may resemble autoinflammatory diseases, but the etiology is not fully understood.
- Open Access
- 14 October 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 258
Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome
A Giardia outbreak was associated with development of post-infectious functional gastrointestinal disorders (PI-FGID) and chronic fatigue syndrome (PI-CFS). Markers of immune dysfunction have given conflicting results in CFS and FGID patient populations. The aim of this study was to evaluate a wide selection of markers of immune dysfunction in these two co-occurring post-infectious syndromes.
- 14 October 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 258
Open AccessImmunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome
A Giardia outbreak was associated with development of post-infectious functional gastrointestinal disorders (PI-FGID) and chronic fatigue syndrome (PI-CFS). Markers of immune dysfunction have given conflicting results in CFS and FGID patient populations. The aim of this study was to evaluate a wide selection of markers of immune dysfunction in these two co-occurring post-infectious syndromes.
- 1 July 1996
- Published by Wiley in European Journal of Immunology
- Vol. 26 (7) , 1668-1671
Co‐localization of the neonatal Fcγ receptor and IgG in human placental term syncytiotrophoblasts
Transfer of maternal IgG through the human placenta furnishes the newborn with passive immunity to a number of infectious agents. The exact mechanism of this transfer is still unknown, but it is agreed that it involves active receptor‐mediated transport. The neonatal Fc receptor is a major histocompatibility complex class I‐like receptor originally identified in the intestines of newborn rodents. A similar receptor has recently been detected in human placental syncytiotrophoblasts. Using multilabeling fluorescence immunohistochemistry and confocal laser scanning microscopy, we found that the neonatal Fc receptor co‐localizes with IgG and β2‐microglobulin in granules of human placental syncytiotrophoblast. The Fc receptor is not detected on syncytiotrophoblast apical plasma membrane. Localization to the outermost cellular barrier between the fetal and maternal blood further strengthens the role of the Fc receptor in transplacental transport of IgG.
- 1 July 1996
- Published by Wiley in European Journal of Immunology
- Vol. 26 (7) , 1668-1671
Co‐localization of the neonatal Fcγ receptor and IgG in human placental term syncytiotrophoblasts
Transfer of maternal IgG through the human placenta furnishes the newborn with passive immunity to a number of infectious agents. The exact mechanism of this transfer is still unknown, but it is agreed that it involves active receptor‐mediated transport. The neonatal Fc receptor is a major histocompatibility complex class I‐like receptor originally identified in the intestines of newborn rodents. A similar receptor has recently been detected in human placental syncytiotrophoblasts. Using multilabeling fluorescence immunohistochemistry and confocal laser scanning microscopy, we found that the neonatal Fc receptor co‐localizes with IgG and β2‐microglobulin in granules of human placental syncytiotrophoblast. The Fc receptor is not detected on syncytiotrophoblast apical plasma membrane. Localization to the outermost cellular barrier between the fetal and maternal blood further strengthens the role of the Fc receptor in transplacental transport of IgG.
- 1 February 1996
- Published by Wiley in European Journal of Immunology
- Vol. 26 (2) , 505-507
Co‐localization of β2‐microglobulin and IgG in human placental syncytiotrophoblasts
The fetal syncytiotrophoblast cells in close contact with maternal blood circulation apparently lack surface expression of HLA molecules, including the HLA light chain β2‐microglobulin. This is thought to contribute significantly to a successful pregnancy. We find that syncytiotrophoblasts do express β2‐microglobulin. β2‐microglobulin is primarily localized intracellularly in apical granules, and co‐localize with human IgG. The origin and function of syncytiotrophoblast β2‐microglobulin is unknown, but its localization in the syncytiotrophoblasts may implicate β2‐microglobulin in the transplacental transport of IgG in conjunction with a recently identified class I HLA‐like receptor for IgG/Fc. Alternatively, β2‐microglobulin may associate with a hitherto unidentified class I HLA molecule.
- 1 February 1996
- Published by Wiley in European Journal of Immunology
- Vol. 26 (2) , 505-507
Co‐localization of β2‐microglobulin and IgG in human placental syncytiotrophoblasts
The fetal syncytiotrophoblast cells in close contact with maternal blood circulation apparently lack surface expression of HLA molecules, including the HLA light chain β2‐microglobulin. This is thought to contribute significantly to a successful pregnancy. We find that syncytiotrophoblasts do express β2‐microglobulin. β2‐microglobulin is primarily localized intracellularly in apical granules, and co‐localize with human IgG. The origin and function of syncytiotrophoblast β2‐microglobulin is unknown, but its localization in the syncytiotrophoblasts may implicate β2‐microglobulin in the transplacental transport of IgG in conjunction with a recently identified class I HLA‐like receptor for IgG/Fc. Alternatively, β2‐microglobulin may associate with a hitherto unidentified class I HLA molecule.